Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis
Many individuals infected with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) develop no or only mild symptoms, but some can go on onto develop a spectrum of pathologies including pneumonia, acute respiratory distress syndrome, respiratory failure, systemic inflammation, and multio...
Main Authors: | Eugenio Hardy, Carlos Fernandez-Patron |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/3/390 |
Similar Items
-
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients
by: Carolina D`Avila-Mesquita, et al.
Published: (2021-10-01) -
Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans
by: Yi-Ting Chen, et al.
Published: (2012-10-01) -
LPS aggravates lung inflammation induced by RSV by promoting the ERK-MMP-12 signaling pathway in mice
by: Shenglin Chen, et al.
Published: (2020-07-01) -
Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke
by: Fang-I Hsieh, et al.
Published: (2019-11-01) -
Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse
by: Luiz G. Gardinassi, et al.
Published: (2020-06-01)